about
Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspectiveSafety, pharmacokinetics, and pharmacodynamics of cyclodextrin itraconazole in pediatric patients with oropharyngeal candidiasisIntravenous itraconazole.Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics.The use of itraconazole as prophylaxis against invasive fungal infection in blood and marrow transplant recipients.Current pharmacotherapy of allergic bronchopulmonary aspergillosis.Cyclodextrins in drug delivery: an updated reviewCyclodextrins.Pharmacotherapy of Candida bloodstream infections: new treatment options, new era.Antifungal drug resistance.Itraconazole--perspectives for the management of invasive aspergillosis.Systemic antifungal therapy: new options, new challenges.Invasive aspergillosis in patients with hematologic malignancies.Pharmacotherapy of onychomycosis.Azole therapy of clinical and experimental coccidioidomycosis.Emerging therapeutic agents for onychomycosis.Antifungal therapeutic drug monitoring: established and emerging indications.Current concepts in antifungal pharmacology.Bioavailability of phytochemicals and its enhancement by drug delivery systems.Cyclodextrin complexes for treatment improvement in infectious diseases.Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.Studies on itraconazole delivery and pharmacokinetics in mallard ducks (Anas platyrhynchos).Candida urinary tract infections--treatment.An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients.
P2860
Q27009221-D89784DA-56EA-4781-BFC8-883F71B8B8A9Q34111158-2407EB60-D2DA-4673-B3AD-08135122400AQ34284268-870EA093-B52F-44FD-8E90-EBBE6C193AACQ34291656-51F1B291-72CB-4C7D-8787-BC2C4EA0CEB3Q34294914-AC33CA71-CBBF-40AE-8E22-B76B1835BEDCQ34388546-534D1073-4235-4B73-BBD9-111EEDD7206BQ34563402-31521995-AD89-47ED-88D1-A395A76BCD12Q34761190-99123360-FB30-4AAB-BF33-3345133EF41CQ34768471-7BF48EEE-CDBF-4518-BFC2-6420EB996364Q35040008-4DA3A924-4E8F-4BB2-89F0-30992D460057Q35105394-010284CC-911F-462F-8FBF-689CE1E7FEBEQ35585219-5FE71017-326E-4E75-9849-4692C9305EC7Q35616161-84E2FCC6-BA6A-427D-AFFA-54609B8F67B3Q36150713-71502D0B-49B7-44E8-82B0-B80A88F5DE1AQ36754048-93E94F1C-4EFA-4C89-913F-86A10CDDAF38Q36943999-16B4484F-D645-4FB7-B2B8-DAC85D2468E4Q37310029-F522A91C-5C03-4759-B059-31C1C984C35CQ37908856-7B996BF7-01CC-4EA8-B58D-4FB6E23BC4F8Q38084084-74E1BDF5-DBF5-48A2-833E-B2CD09501576Q38501664-F9B1AAEA-A234-48EF-929A-238A72C70EDCQ43732838-97D1C99D-F3CF-40A1-9265-F19855D5B797Q46248558-D592348E-F39F-48BD-B610-4C3057DBFD5DQ51175452-9F602B65-0328-40CF-8B94-89BFC64B033EQ54394711-387E3BEF-0CAF-45DD-B804-463EE44CEBD8
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Itraconazole in cyclodextrin solution.
@ast
Itraconazole in cyclodextrin solution.
@en
type
label
Itraconazole in cyclodextrin solution.
@ast
Itraconazole in cyclodextrin solution.
@en
prefLabel
Itraconazole in cyclodextrin solution.
@ast
Itraconazole in cyclodextrin solution.
@en
P2860
P1433
P1476
Itraconazole in cyclodextrin solution.
@en
P2093
Stevens DA
P2860
P304
P356
10.1592/PHCO.19.8.603.31529
P407
P577
1999-05-01T00:00:00Z